KAYLA OBERNESSER: Open Payments
NPI 1124754486 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 24 payments from 12 companies in 2025. Trend: 2023 $2,067 · 2024 $1,552 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Merck Sharp & Dohme LLC | 6 | $107 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Genentech USA, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $26 |
| INTUITIVE SURGICAL, INC. | 1 | $20 |
| Lilly USA, LLC | 3 | $17 |
| Incyte Corporation | 1 | $15 |
Products named: ENHERTU, KEYTRUDA, KISQALI, PLUVICTO, Itovebi, NINLARO, SARCLISA, Da Vinci Surgical System.
Industry payments across IL — which companies pay providers there.
